Cancer Cytopathology

Papers
(The H4-Index of Cancer Cytopathology is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Urine cytology in the detection of renal cell carcinomas – a territory‐wide multi‐institutional retrospective review of more than 2 decades875376689
Growing threats of a mass exodus in governmental public health809120313
Commentary on small‐volume biopsy of follicular lymphoma: Practical issues in the molecular era540160058
Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment59
ThyroSeq v3 for Bethesda III and IV: An institutional experience45
Global impact of the COVID‐19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries41
Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID‐19) infection: Perspectives from Taiwan37
Tumor mutational burden on cytological samples: A pilot study34
Diagnostic performances of the Afirma Gene Sequencing Classifier in comparison with the Gene Expression Classifier: A meta‐analysis34
The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision‐making from a fine‐needle aspiration sample33
Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma30
Thyroid cytology smear slides: An untapped resource for ThyroSeq testing28
Assessing the diagnostic accuracy for pleomorphic adenoma and Warthin tumor by employing the Milan System for Reporting Salivary Gland Cytopathology: An international, multi‐institutional study27
Cytologic and histologic samples from patients infected by the novel coronavirus 2019 SARS‐CoV‐2: An Italian institutional experience focusing on biosafety procedures27
Identification of circulating tumor cells using 4‐color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low‐dose computed tomography–det26
Considerations for remote learning in pathology during COVID‐19 social distancing25
Evidence‐based diagnostic performance of novel biomarkers for the diagnosis of malignant mesothelioma in effusion cytology24
Cytologic grading of primary malignant salivary gland tumors: A blinded review by an international panel24
A deep learning system to diagnose the malignant potential of urothelial carcinoma cells in cytology specimens21
Measures to reduce diagnostic error and improve clinical decision making in thyroid FNA aspiration cytology: A proposed framework20
Utilization of cytology smears improves success rates of RNA‐based next‐generation sequencing gene fusion assays for clinically relevant predictive biomarkers20
Assessment of risk of malignancy by application of the proposed Sydney system for classification and reporting lymph node cytopathology20
Sensitivity of cervico‐vaginal cytology in endometrial carcinoma: A systematic review and meta‐analysis20
0.038012981414795